Motor Neuron Transduction After Intracisternal Delivery of AAV9 in a Cynomolgus Macaque

被引:5
|
作者
Bell, Peter [1 ]
Hinderer, Christian [1 ]
Louboutin, Jean-Pierre [2 ]
Yu, Hongwei [1 ]
Grant, Rebecca [1 ]
Bote, Erin [1 ]
Wilson, James M. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA
[2] Univ W Indies, Dept Basic Med Sci, Sect Anat, Mona, Jamaica
关键词
NONHUMAN-PRIMATES;
D O I
10.1089/hgtb.2015.041
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The image shows a section of the lumbar spinal cord from a cynomolgus macaque that had received AAV9.CB.EGFP via the cisterna magna. Expression of GFP in multiple motor neurons is visible. Injection into the cerebrospinal fluid has been shown to be an effective route of vector administration for neuron transduction.
引用
收藏
页码:43 / 44
页数:2
相关论文
共 50 条
  • [21] Enhanced Cochlear Transduction by AAV9 with High-Concentration Sucrose
    Noda, Masao
    Koshu, Ryota
    Dias, Mari Shimada
    Saito, Chizu
    Takino, Naomi
    Ito, Mika
    Yoshimura, Hidekane
    Ito, Makoto
    Muramatsu, Shin-ichi
    HUMAN GENE THERAPY, 2023, 34 (19-20) : 1064 - 1071
  • [22] Pretreatment with IVIG Reduces Peripheral Transduction of AAV9 Delivered to the CNS
    West, Cara
    Mastis, Bryan
    Vandenberghe, Luk H.
    Richman, Laura K.
    Calcedo, Roberto
    MOLECULAR THERAPY, 2022, 30 (04) : 21 - 21
  • [23] Biodistribution and Safety Comparison of AAV9 and AAV9PHP.B in Three Mouse Strains and Cynomolgus Macaques
    Scott, David W.
    Rouse, Jeremy
    Romero, Kirsten
    Annas, Abigail
    Hekele, Armin
    Beard, Clayton W.
    MOLECULAR THERAPY, 2022, 30 (04) : 79 - 79
  • [24] Profile of Circulating and Neutralizing Antibody Titers Towards AAV8 & AAV9 in Cynomolgus Macaques
    Golebiowski, Diane
    Conlon, Thomas J.
    Coleman, Kirsten E.
    Hewitt, Matthew M.
    Morris, Carl A.
    Schneider, Joel S.
    MOLECULAR THERAPY, 2017, 25 (05) : 128 - 128
  • [25] Mouse Gender Influences Brain Transduction by Intravascularly Administered AAV9
    Maguire, Casey A.
    Crommentuijn, Matheus H. W.
    Mu, Dakai
    Hudry, Eloise
    Serrano-Pozo, Alberto
    Hyman, Bradley T.
    Tannous, Bakhos A.
    MOLECULAR THERAPY, 2013, 21 (08) : 1469 - 1470
  • [26] Biodistributional Study of Novel AAV-F Capsid vs AAV9 after Neonatal Intravenous Delivery
    Keegan, Anna
    Chu, Wing Sum
    Chilcott, Ellie
    Antinao, Juan Diaz
    Joanne, Ng
    Waddington, Simon
    Karda, Rajvinder
    MOLECULAR THERAPY, 2023, 31 (04) : 232 - 232
  • [27] Investigation of Hindlimb Clasping Following Intrathecal AAV9 Delivery
    Eller, Meghan
    Knight, Krishanna
    Garza, Irvin T.
    Bailey, Rachel M.
    MOLECULAR THERAPY, 2023, 31 (04) : 364 - 365
  • [28] Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
    Duque, Sandra
    Joussemet, Beatrice
    Riviere, Christel
    Marais, Thibaut
    Dubreil, Laurence
    Douar, Anne-Marie
    Fyfe, John
    Moullier, Philippe
    Colle, Marie-Anne
    Barkats, Martine
    MOLECULAR THERAPY, 2009, 17 (07) : 1187 - 1196
  • [29] Improved AAV9 Transduction of the Central Nervous System and Retina After Co-Treatment with Neuraminidase
    Schwartz, Maura
    Huffenberger, Amy
    Pineda, Ricardo
    Baird, Megan
    Likhite, Shibi
    Meyer, Kathrin
    MOLECULAR THERAPY, 2020, 28 (04) : 92 - 92
  • [30] AAV9 Capsid Variants with Improved CNS Transduction Identified by Directed Evolution
    Rohovie, Marcus
    Kruse, Nikki
    Schmitt, Christopher
    Wong, Victoria
    Sero, Antoinette
    Rivera-Velazquez, Mirella
    Lee, Grace
    Desautel, Sarah
    Del Greco, Elizabeth
    Sedighi, Faezeh
    Nivina, Aleksandra
    Jenne, Stephan
    Gebretsadik, Kahsay
    Kumar, Ambuj
    Chng, Chinping
    Akeefe, Hassibullah
    Silverman, Adam
    MOLECULAR THERAPY, 2023, 31 (04) : 661 - 661